COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 5/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/24

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Source: supplementary table 3

Description: differential abundance of mothers at one week post second dose of BNT162b2 when compared to baseline.

Abundance in Group 1: increased abundance in Mothers at one week post-second dose

NCBI	Quality Control	Links
Acinetobacter baumannii
Acinetobacter soli
Acinetobacter ursingii
Brevundimonas olei
Epilithonimonas hominis
Moraxella atlantae
Moraxella porci
Paenibacillus macerans
Peredibacter starrii
Prevotella melaninogenica
Roseomonas gilardii
unclassified Acinetobacter
unclassified Actinobacillus
unclassified Brevundimonas
unclassified Chitinophagaceae
unclassified Gemmobacter
unclassified Gordonia (in: high G+C Gram-positive bacteria)
unclassified Klebsiella
unclassified Leptotrichia
unclassified Megamonas
unclassified Nautella
unclassified Neptunomonas
unclassified Ochrobactrum
unclassified Paracoccaceae
unclassified Peptoniphilus
unclassified Serratia (in: enterobacteria)
unclassified Vogesella
uncultured Clostridia bacterium
uncultured Paraburkholderia sp.
Clostridiales bacterium
unclassified Eubacterium (in: firmicutes)
unclassified Pseudarcobacter
unclassified Sandaracinobacter

Revision editor(s): Folakunmi, ChiomaBlessing